MX2009002402A - Ribointerruptores de glms, diseño de compuesto basado en su estructura con ribointerruptores de glms y metodos y composiciones para el uso de los mismos y con ribointerruptores de glms. - Google Patents

Ribointerruptores de glms, diseño de compuesto basado en su estructura con ribointerruptores de glms y metodos y composiciones para el uso de los mismos y con ribointerruptores de glms.

Info

Publication number
MX2009002402A
MX2009002402A MX2009002402A MX2009002402A MX2009002402A MX 2009002402 A MX2009002402 A MX 2009002402A MX 2009002402 A MX2009002402 A MX 2009002402A MX 2009002402 A MX2009002402 A MX 2009002402A MX 2009002402 A MX2009002402 A MX 2009002402A
Authority
MX
Mexico
Prior art keywords
glms
riboswitches
glms riboswitches
compositions
methods
Prior art date
Application number
MX2009002402A
Other languages
English (en)
Inventor
Ronald R Breaker
Jinsoo Lim
Scotta A Strobel
Jesse C Cochrane
Original Assignee
Univ Yale
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Yale filed Critical Univ Yale
Publication of MX2009002402A publication Critical patent/MX2009002402A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7008—Compounds having an amino group directly attached to a carbon atom of the saccharide radical, e.g. D-galactosamine, ranimustine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/655—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms
    • C07F9/6552—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms the oxygen atom being part of a six-membered ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H11/00—Compounds containing saccharide radicals esterified by inorganic acids; Metal salts thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6897—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids involving reporter genes operably linked to promoters
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16C—COMPUTATIONAL CHEMISTRY; CHEMOINFORMATICS; COMPUTATIONAL MATERIALS SCIENCE
    • G16C20/00—Chemoinformatics, i.e. ICT specially adapted for the handling of physicochemical or structural data of chemical particles, elements, compounds or mixtures
    • G16C20/50—Molecular design, e.g. of drugs

Abstract

El ribointerruptor de glmS en un blanco para antibióticos y otras terapias de moléculas pequeñas. Los compuestos pueden utilizarse para estimular, activar, inhibir y/o inactivar el ribointerruptor de glmS. Las estructuras atómicas del ribointerruptor de glmS pueden usarse para diseñar nuevos compuestos con el fin de estimular, activar, inhibir y/o inactivar ribointerruptores.
MX2009002402A 2006-09-06 2007-09-06 Ribointerruptores de glms, diseño de compuesto basado en su estructura con ribointerruptores de glms y metodos y composiciones para el uso de los mismos y con ribointerruptores de glms. MX2009002402A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US84287006P 2006-09-06 2006-09-06
US84484406P 2006-09-16 2006-09-16
PCT/US2007/019456 WO2008076156A2 (en) 2006-09-06 2007-09-06 Glms riboswitches, structure-based compound design with glms riboswitches, and methods and compositions for use of and with glms riboswitches

Publications (1)

Publication Number Publication Date
MX2009002402A true MX2009002402A (es) 2009-04-02

Family

ID=39536867

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2009002402A MX2009002402A (es) 2006-09-06 2007-09-06 Ribointerruptores de glms, diseño de compuesto basado en su estructura con ribointerruptores de glms y metodos y composiciones para el uso de los mismos y con ribointerruptores de glms.

Country Status (9)

Country Link
US (1) US20100324123A1 (es)
EP (1) EP2061480A4 (es)
JP (1) JP2010503619A (es)
KR (1) KR20090073131A (es)
AU (1) AU2007334618A1 (es)
CA (1) CA2662506A1 (es)
MX (1) MX2009002402A (es)
SG (1) SG175549A1 (es)
WO (1) WO2008076156A2 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2322535A3 (en) 2002-09-20 2011-09-28 Yale University Riboswitches, methods for their use, and compositions for use with riboswitches
US8313901B2 (en) 2005-12-21 2012-11-20 Yale University Methods and compositions related to the modulation of riboswitches
CN107760643B (zh) * 2017-11-15 2020-10-09 江南大学 一种提高枯草芽孢杆菌乙酰氨基葡萄糖产量的方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8313901B2 (en) * 2005-12-21 2012-11-20 Yale University Methods and compositions related to the modulation of riboswitches

Also Published As

Publication number Publication date
EP2061480A4 (en) 2011-07-13
CA2662506A1 (en) 2008-06-26
WO2008076156A2 (en) 2008-06-26
AU2007334618A1 (en) 2008-06-26
JP2010503619A (ja) 2010-02-04
KR20090073131A (ko) 2009-07-02
EP2061480A2 (en) 2009-05-27
US20100324123A1 (en) 2010-12-23
WO2008076156A3 (en) 2009-04-16
SG175549A1 (en) 2011-11-28

Similar Documents

Publication Publication Date Title
MX2009012773A (es) Ribointerruptores y metodos y composiciones para usarse de y con ribointerruptores.
TN2010000131A1 (en) Polo-like kinase inhibitors
GT200600171A (es) Proceso quimico
EP1828953A4 (en) RIBOCOMMUTATEURS, STRUCTURE OF RIBOCOMMUTATE COMPOUNDS, AND METHODS AND COMPOSITIONS USED WITH RIBOCOMMUTATEURS
PH12016500072A1 (en) Piperidinyl-indole derivatives complement factor b inhibitors and uses thereof
HK1131146A1 (en) Heteroaryl compounds, compositions thereof, and use thereof as protein kinase inhibitors
WO2014188178A9 (en) Polymyxin derivatives and their use in combination therapy together with different antibiotics
MX336381B (es) Boronatos como inhibidores de arginasa.
MX337906B (es) Compuestos de heteroarilo, composiciones de los mismos, y su uso como inhibidores de proteina cinasas.
MY159230A (en) P38 map kinase inhibitors
MX338707B (es) Compuestos heterociclicos activadores de proteina cinasa activada por 5'-amp (ampk) y metodos para emplearlos.
NZ620020A (en) Heterocyclic compounds and uses thereof
BR112012019511A2 (pt) compostos de pirrolo [2,3-d] pirimidina como inibidores de jak.
AR068369A1 (es) Sal de xinafoato de n4-[(2,2-difluor-4h-benzo[1,4]oxazin-3-on)-6-il]-5-fluor-n2-[3-(metilaminocarbonilmetilenoxi)-fenil]2,4-pirimidindiamina"
TW200740815A (en) P38 MAP kinase inhibitors and methods for using the same
CL2009000393A1 (es) Composición farmaceutica que comprende a) un agente farmaceutico activable, b) un agente activo plasmonico; util para el tratamiento de trastornos de proliferación celular.
UA115320C2 (uk) Інгібітори кінази
UY31080A1 (es) Derivados de pirazol sustituidos con heteroarilo utiles para tratar trastornos hiperproliferativos y enfermedades asociadas con angiogénesis
EA201170680A1 (ru) Ингибиторы акт и p70 s6-киназы
GB201021864D0 (en) Organic compounds
BRPI0408353A (pt) composto, composição farmacêutica, métodos para o tratamento de neoplasias suscetìveis e para o tratamento de infecções virais, e, uso de um composto
CL2011001026A1 (es) Uso de pimobedan para preparar un medicamento util en el tratamiento de cardiomiopatia hipertrofica en un gato.
BR112014012983A2 (pt) derivados de pirrol
MX2015007940A (es) Compuestos tricíclicos como inhibidores de cftr.
IN2015DN03235A (es)

Legal Events

Date Code Title Description
FG Grant or registration